1 Min Read
Aug 10 (Reuters) - Apellis Pharmaceuticals Inc
* Closing of a $60 million Series E preferred stock financing led by Sectoral Asset Management Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.